Literature DB >> 4347994

Immunologic manipulation of metastases due to herpesvirus transformed cells.

R Duff, E Doller, F Rapp.   

Abstract

Herpes simplex virus type 1 (HSV-1), type 2 (HSV-2), and simian virus 40 (SV40) fail to induce immunity in weanling Syrian hamsters to transplant of hamster cells transformed by HSV-2. However, the development of metastatic tumors is markedly enhanced by prior immunization with HSV-1. Immunization with SV40, ultraviolet-irradiated tumor cells, or ultraviolet-irradiated normal hamster embryo cells inhibits the development of metastases. The HSV-hamster system appears a good one for the study of development, prevention, and control of metastases by mammalian cells transformed by a common human virus.

Entities:  

Mesh:

Year:  1973        PMID: 4347994     DOI: 10.1126/science.180.4081.79

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  Transformation of primary hamster embryo fibroblasts by type 2 simplex virus: evidence for a "hit and run" mechanism.

Authors:  G R Skinner
Journal:  Br J Exp Pathol       Date:  1976-08

2.  The role of immunology in the diagnosis, prognosis and treatment planning of oral cancer.

Authors:  E J Shillitoe
Journal:  Proc R Soc Med       Date:  1976-10

3.  Characterization of metastasis-associated antigens on RAW117 lymphosarcoma cell lines.

Authors:  S S Joshi; J G Sharp; H M Gharpure; K W Brunson
Journal:  Clin Exp Metastasis       Date:  1987 Jan-Mar       Impact factor: 5.150

4.  Neoplasms, differentiations and mutations.

Authors:  G B Pierce
Journal:  Am J Pathol       Date:  1974-10       Impact factor: 4.307

Review 5.  Are viruses important in carcinogenesis?

Authors:  F Rapp; E R Buss
Journal:  Am J Pathol       Date:  1974-10       Impact factor: 4.307

6.  Host immunity to mycoplasma antigens introduced into B16 melanoma cells: effect on tumor growth rate and metastasis.

Authors:  C W Stackpole; A L Alterman; D M Fornabaio
Journal:  Clin Exp Metastasis       Date:  1988 Jul-Aug       Impact factor: 5.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.